A survey on the treatment of atrial Fibrillation in South Africa

South African Medical Journal

Volumn 104, Issue 9, 2014, Pages 623-627

  Jardine, R M ^a   Fine, J ^a   Obel, I W P ^b  

^a Linmed Hospital ^*  (South Africa)

^b MILPARK HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ARTERY EMBOLISM; ARTICLE; BRAIN HEMORRHAGE; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; MORBIDITY; NEW YORK HEART ASSOCIATION CLASS; OBESITY; OBSERVATIONAL STUDY; SINUS RHYTHM; SMOKING; SOUTH AFRICA; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMPLICATION; COST OF ILLNESS; ELECTROCARDIOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; REGISTER; STROKE; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SOUTH AFRICA; STROKE; WARFARIN; YOUNG ADULT;

EID: 84906543090     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/SAMJ.8111     Document Type: Article

References (14)

1. Greenlee RT, Vidaillet H. Recent progress in the epidemiology of atrial fibrillation. Curr Opin Cardiol 2005;20(1):7-14.
2. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju P.M. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74(3):236-241.[http://dx.doi.org/10.1016/0002-9149(94)90363-8]
3. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart R.G. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155(5):469-473.[http://dx.doi.org/10.1001/archinte.155.5.469]
4. Wattigney WA, Mensah GA, Croft J.B. Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol 2002;155(9):819-826.[http://dx.doi.org/10.1093/aje/155.9.819]
5. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications of for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285(18):2370-2375.[http://dx.doi.org/10.1001/jama.285.18.2370]
6. Ryder KM, Benjamin E.J. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999;84(9A):131R-138R.[http://dx.doi.org/10.1016/S0002-9149(99)00713-4]
7. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Executive summary. Eur Heart J 2006;27(16):1979-2030.[http://dx.doi.org/10.1093/eurheartj/ehl176]
8. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Eur Heart J 2010;31(19):2369-2429.[http://dx.doi.org/10.1093/eurheartj/ehq278]
9. Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline). Heart Rhythm 2011;8(1):157-176.[http://dx.doi.org/I10.1016/j.hrthm.2010.11.047]
10. Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012;33(21):2719-2747.[http://dx.doi.org/10.1093/eurheartj/ehs253]
11. Nieuwlaat R, Capucci A, Camm AJ, et al. Atrial fibrillation management: A prospective survey in ESC member countries-the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26(22):2422-2434.[http://dx.doi.org/10.1093/eurheartj/ehi505]
12. Camm AJ, Breithardt G, Crijns H, et al. Real life observations of clinical outcomes with rhythm-and rate control therapies for atrial fibrillation-RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 2011;58(5):493-501.[http://dx.doi.org/10.1016/j.jacc.2011.03.03]
13. Sliwa K, Carrington MJ, Klug E, et al. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: Insights from the Heart of Soweto Study. Heart 2010;96(23):1878-1882.[http://dx.doi.org/10.1136/hrt.2010.206938]
14. Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink D.N. Rates of haemorrhage during warfarin therapy for atrial fibrillation. CMAJ 2013;185(2):E121-E127.[http://dx.doi. org/10.1503/cmaj.121218]